You just read:

New data presented at the ISTH 2015 Congress show Idarucizumab* results in immediate reversal of dabigatran in patients requiring urgent medical procedures or with serious bleeding complications(1,2)

News provided by

Boehringer Ingelheim (Canada) Ltd.

Jun 22, 2015, 08:05 ET